Obstructive sleep apnea, inflammation, and the metabolic syndrome

Metabolic Syndrome and Related Disorders

Volumn 7, Issue 4, 2009, Pages 271-277

  Calvin, Andrew D ^a   Albuquerque, Felipe N ^b   Lopez Jimenez, Francisco ^b   Somers, Virend K ^b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; INSULIN; REACTIVE OXYGEN METABOLITE;

DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; EPIDEMIC; GLUCOSE HOMEOSTASIS; HUMAN; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOXIA; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION;

ADIPOKINES; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; OBESITY; REACTIVE OXYGEN SPECIES; SLEEP APNEA, OBSTRUCTIVE;

EID: 68649118427     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2008.0093     Document Type: Review

References (117)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. The Lancet 2005;365:1415-1428.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) JAMA 2001;285: 2486-2497.
3. Ford ES, Giles WH, Dietz WH. Prevalence of the Metabolic Syndrome Among US Adults: Findings From the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359. (Pubitemid 34251969)
4. Wilcox I, McNamara S, Collins F, Grunstein R, Sullivan C. "Syndrome Z": The interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 1998;53(S):25-28. (Pubitemid 28467811)
5. Somers VK, White DP, Amin R, et al. Sleep Apnea and Cardiovascular Disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). J Amn Coll Cardiol 2008;52:686-717.
6. Schwab RJ, Pasirstein M, Pierson R, et al. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med 2003;168:522-530. (Pubitemid 37088593)
7. Fogel RB, Malhotra A, Pillar G, et al. Genioglossal activation in patients with obstructive sleep apnea versus control subjects. Mechanisms of muscle control. Am J Respir Crit Care Med 2001;164:2025-2030. (Pubitemid 34020243)
8. Fogel RB, Trinder J, Malhotra A, et al. Within-breath control of genioglossal muscle activation in humans: Effect of sleepwake state. J Physiol 2003;550:899-910. (Pubitemid 37010072)
9. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-689.
10. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 1993;328:303-307. (Pubitemid 23035328)
11. Somers VK, Mark AL, Zavala DC, Abboud FM. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 1989;67:2101-2106. (Pubitemid 20039424)
12. Somers VK, Mark AL, Zavala DC, Abboud FM. Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol 1989;67:2095-2100.
13. Hla KM, Young TB, Bidwell T, Palta M, Skatrud JB, Dempsey J. Sleep apnea and hypertension: A population-based study. Ann Intern Med 1994;120:382-388. (Pubitemid 24066635)
14. Haentjens P, Van Meerhaeghe A, Moscariello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: Evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007;167757-167764
15. Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007;50:417-423. (Pubitemid 47205794)
16. Alajmi M, Mulgrew A, Fox J, et al. Impact of continuous positive airway Pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: A meta-analysis of randomized controlled trials. Lung 2007;185:67-72. (Pubitemid 46571874)
17. Romero-Corral A, Somers VK, Pellikka PA, et al. Decreased right and left ventricular myocardial performance in obstructive sleep apnea. Chest 2007;132:1863-1870.
18. Chan J, Sanderson J, Chan W, et al. Prevalence of sleep-disordered breathing in diastolic heart failure. Chest 1997;111: 1488-1493. (Pubitemid 27260070)
19. Arias MA, Garcia-Rio F, Alonso-Fernandez A, Mediano O, Martinez I, Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function: Effects of nasal continuous positive airway pressure in men. Circulation 2005;112:375-383. (Pubitemid 41022078)
20. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034-2041. (Pubitemid 41609096)
21. Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin KA. Increased risk of stroke in patients with coronary artery disease and sleep apnea: A 10-year follow-up. Circulation 2008;118:955-960.
22. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005;352:1206-1214.
23. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235. (Pubitemid 23115702)
24. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PMA, Wilding JPH. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004;25:735-741. (Pubitemid 38647933)
25. Gruber A, Horwood F, Sithole J, Ali NJ, Idris I. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc r Diabetol 2006;5:22.
26. Lam JCM, Lam B, Lam C-l, et al. Obstructive sleep apnea and the metabolic syndrome in community-based Chinese adults in Hong Kong. Respir Med 2006;100:980-987.
27. Coughlin SR, Mawdsley L, Mugarza JA, Wilding JPH, Calverley PMA. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 2007;29:720-727. (Pubitemid 46554622)
28. Cho N, Joo S, Kim J, et al. Relation of habitual snoring with components of metabolic syndrome in Korean adults. Diabetes Res Clin Pract 2006;71:256-263. (Pubitemid 43295248)
29. Newman AB, Nieto FJ, Guidry U, et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: The Sleep Heart Health Study. Am. J. Epidemiol 2001;154:50-59. (Pubitemid 32565686)
30. McArdle N, Hillman D, Beilin L, Watts G. Metabolic risk factors for vascular disease in obstructive sleep apnea: A matched controlled study. Am J Respir Crit Care Med 2007;175: 190-195. (Pubitemid 46115091)
31. Kono M, Tatsumi K, Saibara T, et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 2007;131:1387-1392. (Pubitemid 46762343)
32. Sharma SK, Kumpawat S, Goel A, Banga A, Ramakrishnan L, Chaturvedi P. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 2007;8:12-17. (Pubitemid 46044133)
33. Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994;79:1681-1685.
34. Al-Delaimy WK, Manson JE, Willett WC, Stampfer MJ, Hu FB. Snoring as a risk factor for type II diabetes mellitus: A prospective study. Am J Epidemiol 2002;155:387-393. (Pubitemid 34174148)
35. Elmasry A, Janson, C, Lindberg, E, Gislason, T, Tageldin, MA, Boman, G. The role of habitual snoring and obesity in the development of diabetes: A 10-year follow-up study in a male population. J Intern Med 2000;248:13-20. (Pubitemid 30469999)
36. Ip MSM, Lam KSL, Ho C-m, Tsang KWT, Lam W-k: Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000;118:580-586. (Pubitemid 30743627)
37. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002;165:677-682.
38. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insulin resistance: The Sleep Heart Health Study. Am. J. Epidemiol 2004;160:521-530. (Pubitemid 39215628)
39. Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: Effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994;79:1681-1685.
40. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: Relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000;85:1151-1158.
41. Tiihonen M, Partinen M, Narvanen S. The severity of obstructive sleep apnoea is associated with insulin resistance. J Sleep Res 1993;2:56-61. (Pubitemid 23137512)
42. Strohl K, Novak R, Singer W, et al. Insulin levels, blood pressure and sleep apnea. Sleep 1994;17:614-618. (Pubitemid 24348453)
43. Harsch IA, Schahin SP, Brückner K, et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 2007;71:252-259.
44. Vgontzas A, Zoumakis, E, Bixler, EO, Lin, HM, Collins, B, Vasta, M, Pejovic, S, Chrousos, GP. Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Investig 2008;38:585-595. (Pubitemid 352019140)
45. Punjabi NM, Ahmed MM, Polotsky VY, Beamer BA, O'Donnell CP. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 2003;136:167-178. (Pubitemid 36809004)
46. Nieuwenhuizen AG, Rutters F. The hypothalamic-pituitaryadrenal-axis in the regulation of energy balance. Physiol Behav 2008;94:169-177.
47. Buckley TM, Schatzberg AF. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: Normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 2005;90:3106-3114.
48. Spath-Schwalbe E, Gofferje M, Kern W, Born J, Fehm H. Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry 1991;29:575-584.
49. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. 354:1435-1439.
50. Vgontzas AN, Pejovic S, Zoumakis E, et al. Hypothalamicpituitary-adrenal Axis activity in obese men with and without sleep apnea: Effects of continuous Positive airway pressure therapy. J Clin Endocrinol Metab 2007;92:4199-4207. (Pubitemid 350074732)
51. Carneiro G, Togeiro SM, Hayashi LF, et al. Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis and 24h blood pressure in men with obstructive sleep apnea ayndrome. Am J Physiol Endocrinol Metab 2008;295:E380-E384.
52. Friberg D. Heavy snorer's disease: A progressive local neuropathy. Acta Oto-Laryngol 1999;119:925-933. (Pubitemid 30126647)
53. Sériès F, Simoneau J, St Pierre S. Muscle fiber area distribution of musculus uvulae in obstructive sleep apnea and non-apneic snorers. Int J Obes Relat Metab Disord 2000;2000:4.
54. Sériès F, Simoneau S, St Pierre, Marc I. Characteristics of the genioglossus and musculus uvulae in sleep apnea hypopnea syndrome and in snorers. Am J Respir Crit Care Med 1996;153:1870-1874. (Pubitemid 26187913)
55. Almendros I, Acerbi I, Puig F, Montserrat J, Navajas D, Farré R. Upper-airway inflammation triggered by vibration in a rat model of snoring. Sleep 2007;30:255-257.
56. Prabhakar NR. Sleep apneas. An oxidative stress? Am J Respir Crit Care Med 2002;165:859-860.
57. Suzuki YJ, Jain V, Park A-M, Day RM. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radical Biol Med . 2006;40: 1683-1692. (Pubitemid 44308121)
58. Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000;162:566-570. (Pubitemid 30647201)
59. Lavie L. Sleep-disordered breathing and cerebrovascular disease: A mechanistic approach. Neurologic Clin 2005;23: 1059-1075. (Pubitemid 41503065)
60. Grattagliano I, Palmieri VO, Portincasa P, Moschetta A, Palasciano G. Oxidative stress-induced risk factors associated with the metabolic syndrome: A unifying hypothesis. J Nutrit Biochem 2008;19:491-504. (Pubitemid 351952322)
61. Hoffmann MS, Singh P, Wolk R, Romero-Corral A, Raghavakaimal S, Somers VK. Microarray studies of genomic oxidative stress and cell cycle responses in obstructive sleep apnea. Antiox Redox Signaling 2007;9:661-669. (Pubitemid 46799098)
62. Lavie L. Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med Rev 2003;7:35-51. (Pubitemid 36188305)
63. McCord JM. The evolution of free radicals and oxidative stress. Am J Med 2000;108:652-659. (Pubitemid 30336605)
64. Haddad JJ. Pharmaco-redox regulation of cytokine-related pathways: from receptor signaling to pharmacogenomics. Free Radical Biol Med 2002;33:907-926. (Pubitemid 35284030)
65. Williams A, Scharf S. Obstructive sleep apnea, cardiovascular disease, and inflammation - is NF-κB the key? Sleep and Breathing 2007;11:69-76. (Pubitemid 46745858)
66. Schafer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 2002;122:829-839.
67. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005;112:2660-2667. (Pubitemid 41532603)
68. Htoo A, Greenberg H, Tongia S, et al. Activation of nuclear factor κB in obstructive sleep apnea: A pathway leading to systemic inflammation. Sleep and Breathing 2006;10:43-50. (Pubitemid 44193436)
69. Yamauchi M, Tamaki S, Tomoda K, et al. Evidence for activation of nuclear factor kappaB in obstructive sleep apnea. Sleep and Breathing 2006;10:189-193. (Pubitemid 44768845)
70. Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, Liu SF. Chronic intermittent hypoxia activates nuclear factor-κB in cardiovascular tissues in vivo. Biochem Biophys Res Commun 2006;343:591-596.
71. Ip MSM, Lam B, Chan L-Y, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000;162:2166-2171. (Pubitemid 32051681)
72. Schulz R, Schmidt D, Blum A, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000;55:1046-1051.
73. McNicholas WT, Bonsignore MR, the Management Committee of ECAB: Sleep apnoea as an independent risk factor for cardiovascular disease: Current evidence, basic mechanisms and research priorities. Eur Respir J 2007;29:156-178.
74. Castell J, Gómez-Lechón M, David M, Fabra R, Trullenque R, Heinrich P. Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990;12:1179-1186.
75. Ridker PM, Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores. Circulation 2004;109:1955-1959. (Pubitemid 38544485)
76. Frohlich M, Imhof A, Berg G, et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 2000;23:1835-1839.
77. Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: Findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 2003;168:351-358. (Pubitemid 36703335)
78. Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-2207.
79. Minoguchi K, Yokoe T, Tazaki T, et al. Increased carotid intimamedia thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 2005;172:625-630. (Pubitemid 41232975)
80. Saletu M, Nosiska D, Kapfhammer G, et al. Structural and serum surrogate markers of cerebrovascular disease in obstructive sleep apnea (OSA). J Neurol 2006;253:746-752.
81. Shamsuzzaman ASM, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002;105:2462-2464. (Pubitemid 34568964)
82. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are Decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129-1134. (Pubitemid 36297204)
83. Can M, Acikgoz S, Mungan G, et al. Serum cardiovascular risk factors in obstructive sleep apnea. Chest 2006;129:233-237. (Pubitemid 43289839)
84. Punjabi N, Beamer B. C-reactive protein is associated with sleep disordered breathing independent of adiposity. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 2007;30:29-34.
85. Larkin EK, Rosen CL, Kirchner HL, et al. Variation of C-reactive protein levels in adolescents: Association with sleep-disordered breathing and sleep duration. Circulation 2005;111:1978-1984.
86. Ryan S, Nolan GM, Hannigan E, Cunningham S, Taylor C, McNicholas WT. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 2007;62:509-514. (Pubitemid 46910129)
87. Patruno V, Aiolfi S, Costantino G, et al. Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea. Chest 2007;131:1393-1399. (Pubitemid 46762344)
88. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R. Effects of CPAP on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic Syndrome. Chest 2008:chest.134:686-692.
89. Barceló A, Barbé F, Llompart E, et al. Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. Am J Med2004;117:118-121.
90. Alam I. KLJWSJNB: Obesity, metabolic syndrome and sleep apnoea: All pro-inflammatory states. Obesity Rev 2007;8:119-127. (Pubitemid 46239440)
91. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-1143.
92. Luc G, Bard J-M, Juhan-Vague I, et al. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: The PRIME Study. Arterioscler Thromb Vasc Biol 2003;23:1255-1261. (Pubitemid 36871282)
93. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive Daytime Sleepiness: Role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997;82:1313-1316. (Pubitemid 27200394)
94. Ciftci TU, Kokturk O, Bukan N, Bilgihan A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 2004;28:87-91. (Pubitemid 39302489)
95. Ryan S, Taylor CT, McNicholas WT. Predictors of elevated nuclear factor-κB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2006;174:824-830. (Pubitemid 44511665)
96. Ciftci TU, Kokturk O, Bukan N, Bilgihan A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 2004;28:87-91. (Pubitemid 39302489)
97. Minoguchi K, Tazaki T, Yokoe T, et al. Elevated production of tumor necrosis factor-α by monocytes in patients with obstructive sleep apnea syndrome. Chest 2004;126:1473-1479. (Pubitemid 39525019)
98. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002;165:934-939. (Pubitemid 34774660)
99. Dyugovskaya L, Lavie P, Lavie L. Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am J Respir Crit Care Med 2003;168:242-249. (Pubitemid 36920981)
100. Mantzoros CS, Moschos S, Avramopoulos I, et al. Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans. J Clin Endocrinol Metab 1997;82:3408-3413. (Pubitemid 27419096)
101. O'Donnell CP, Tankersley CG, Polotsky VP, Schwartz AR, Smith PL. Leptin, obesity, and respiratory function. Respir Physiol 2000;119:163-170.
102. Wolk R, Deb A, Caplice NM, Somers VK. Leptin receptor and functional effects of leptin in human endothelial progenitor cells. Atherosclerosis 2005;183:131-139. (Pubitemid 41416831)
103. Galletti F, Barbato A, Versiero M, et al. Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: An 8-year follow-up study. J Hypertens 2007;25:1671-1677. (Pubitemid 47056575)
104. Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000;279:H234-H237. (Pubitemid 30616665)
105. Sanner BM, Kollhosser P, Buechner N, Zidek W, Tepel M. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J 2004;23:601-604. (Pubitemid 38456004)
106. Barcelo A, Barbe F, Llompart E, et al. Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: Role of obesity. Am J Respir Crit Care Med 2005;171:183-187. (Pubitemid 40105419)
107. Harsch IA, Konturek PC, Koebnick C, et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 2003;22:251-257. (Pubitemid 36986993)
108. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660. (Pubitemid 129516334)
109. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001;50:707-709. (Pubitemid 32242624)
110. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 2006;580:2917-2921.
111. Masserini B, Morpurgo P, Donadio F, et al. Reduced levels of adiponectin in sleep apnea syndrome. J Endocrinol Invest 2006;29:700-705. (Pubitemid 44756174)
112. Wolk R, Svatikova A, Nelson CA, et al. Plasma levels of adiponectin, a novel adipocyte-derived rormone, in sleep apnea. Obesity. 2005;13:186-190.
113. Makino S, Handa, H, Suzukawa, K, Fujiwara, M, Nakamura, M, Muraoka, S, Takasago, I, Tanaka, Y, Hashimoto, K, Sugimoto, T. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol 2006;64:12-19.
114. Kristen L, Knutson EVC. Associations between sleep loss and increased risk of obesity and diabetes. Ann NY Acad Sci 2008;1129:287-304.
115. Barnes M, Houston D, Worsnop CJ, et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 2002;165:773-780. (Pubitemid 34229646)
116. Meier-Ewert HK, Ridker PM, Rifai N, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004;43:678-683. (Pubitemid 38229544)
117. Haack M, Sanchez, E, Mullington, JM. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 2007;30:1145-1152. (Pubitemid 47378957)